Study will help doctors and patients choose best treatment Eylea is most effective for improving the eyesight of patients with poor vision Diabetic macular edema is major cause of…
Researchers reveal new understanding of pathobiology behind vestibular schwannoma
Researchers from the Eaton-Peabody Laboratories of Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology Program in Speech and Hearing Bioscience and Technology have revealed new understanding of the pathobiolo…
Uncategorized
NICE gives qualified nod to Eylea for treatment of diabetic macular edema
The National Institute for Health and Care Excellence has provisionally recommended Eylea as an option for treating diabetic macular edema in preliminary technology appraisal guidance, according to an agency release. Aflibercept (Eylea, Bayer) is recommended when central retinal thickness is 400 µm or more at the start of treatment and when the manufacturer provides aflibercept at an agreed upon discount, according to the agency release.
Uncategorized
NICE gives preliminary recommendation to Ozurdex for DME
The National Institute for Health and Care Excellence has recommended Allergan’s Ozurdex intravitreal dexamethasone implant for the treatment of diabetic macular edema in preliminary technology appraisal guidance, according to an agency release.The organization limited its recommendation to use in aphakic eyes in patients whose diabetic macular edema does not respond to non-corticosteroid treatment or for whom non-corticosteroid treatment is not suitable.
Injectable, ‘self-healing’ hydrogel may offer simpler form of long-term drug delivery
In a new study, MIT researchers reveal how they have created an injectable hydrogel that can deliver two drugs simultaneously over extended time periods.
Physician Bullying: ‘Not Allowed to Cry’
Physician bullies are medicine’s troublemakers. What are some ways to deal with them — and the resulting fallout? Medscape Family Medicine